Although our data revealed the SPP1 as one of molecular mediators underlying the pro-apoptotic effects of concurrent LSD1 and JMJD3 pharmacological inhibition, the detailed molecular mechanisms underlying the synergy between TCP and GSK-J1 in HNSCC remain to be further explored. This evidence concerns the gene KDM6B and head and neck squamous cell carcinoma.